Metastatic Castration-resistant Prostate Cancer trials recruiting in California

All Metastatic Castration-resistant Prostate Cancer trials nationally

Cities in California

Recruiting trials in California

• 64Cu-GRIP B in Patients With Advanced Malignancies
  NCT05888532 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
  NCT07103018 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: San Francisco
• A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
  NCT07005154 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: San Diego
• A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT06879041 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Palo Alto, San Diego
• A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
  NCT04729114 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Anaheim, Santa Rosa
• A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT07719361 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  NCT06842498 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Los Angeles, San Francisco
• A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study
  NCT06531499 · Phase: Phase 1 · Ages: 18 Years to 100 Years · Sex: Male · California: Los Angeles, Palo Alto
• A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
  NCT06533644 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Sacramento
• A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
  NCT07244341 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: La Jolla
• A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
  NCT07213674 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: Duarte, Fullerton, Orange, San Francisco
• A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
  NCT06067841 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Palo Alto
• A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
  NCT06764485 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: Anaheim, La Jolla, Los Alamitos, Los Angeles
• A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
  NCT06629779 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: Anaheim, Fountain Valley, Glendale, Laguna Hills
• A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
  NCT07287150 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Los Angeles, San Francisco
• A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer
  NCT05125016 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · California: Palo Alto
• AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
  NCT07611110 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: Duarte, Irvine, Newport Beach, San Francisco
• Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
  NCT05113537 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• FOG-001 in Locally Advanced or Metastatic Solid Tumors
  NCT05919264 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, Palo Alto, San Francisco, Santa Monica
• Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
  NCT05766371 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: San Francisco
• Study With [225Ac]Ac-FL-020 in mCRPC Participants
  NCT06492122 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Duarte, Irvine, Stanford
• Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
  NCT05489211 · Phase: Phase 2 · Ages: 18 Years to 130 Years · Sex: All (male and female) · California: Los Angeles, San Diego, Santa Rosa
• Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
  NCT05519449 · Phase: Phase 1 · Ages: 18 Years to 100 Years · Sex: Male · California: Los Angeles, Newport Beach, Sacramento, San Francisco
• Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
  NCT07545811 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: La Jolla
• Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer
  NCT06228053 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Los Angeles, San Francisco
• The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
  NCT06520345 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: Orange
• ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
  NCT04986423 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Los Angeles, San Francisco, Whittier